Wrzosek, A.; Drygalski, T.; Nowak, Ł.; Grabowska, I.; Wordliczek, J.; Terlecki, M.; Garlicki, J.
Is There a Rationale for Haemoadsorption with Combined Use of CytoSorb® and Oxiris® in Patients with Underlying Viral Infection and Secondary Bacterial Sepsis? J. Clin. Med. 2025, 14, 6931.
https://doi.org/10.3390/jcm14196931
AMA Style
Wrzosek A, Drygalski T, Nowak Ł, Grabowska I, Wordliczek J, Terlecki M, Garlicki J.
Is There a Rationale for Haemoadsorption with Combined Use of CytoSorb® and Oxiris® in Patients with Underlying Viral Infection and Secondary Bacterial Sepsis? Journal of Clinical Medicine. 2025; 14(19):6931.
https://doi.org/10.3390/jcm14196931
Chicago/Turabian Style
Wrzosek, Anna, Tomasz Drygalski, Łukasz Nowak, Izabella Grabowska, Jerzy Wordliczek, Michał Terlecki, and Jarosław Garlicki.
2025. "Is There a Rationale for Haemoadsorption with Combined Use of CytoSorb® and Oxiris® in Patients with Underlying Viral Infection and Secondary Bacterial Sepsis?" Journal of Clinical Medicine 14, no. 19: 6931.
https://doi.org/10.3390/jcm14196931
APA Style
Wrzosek, A., Drygalski, T., Nowak, Ł., Grabowska, I., Wordliczek, J., Terlecki, M., & Garlicki, J.
(2025). Is There a Rationale for Haemoadsorption with Combined Use of CytoSorb® and Oxiris® in Patients with Underlying Viral Infection and Secondary Bacterial Sepsis? Journal of Clinical Medicine, 14(19), 6931.
https://doi.org/10.3390/jcm14196931
